Name: Boundless Bio, Inc. (BOLD) Balance Sheet
Creator: FinSpry

Boundless Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Boundless Bio, Inc. (BOLD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	26.59	23.71	10.95	34.29
Short-Term Investments	125.53	97.05	55.77	38.74
Cash & Short-Term Investments	152.11	120.75	66.72	73.03
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	2.28	3.45	1.32	1.54
Total Current Assets	154.39	124.20	68.04	74.57
Non-Current Assets
Property, Plant & Equipment (Net)	51.36	4.58	7.73	3.10
Long-Term Investments	0.56	0.00	0.00	34.99
Other Non-Current Assets	0.66	1.12	1.07	1.07
Total Non-Current Assets	52.02	5.69	8.79	39.15
Total Assets	206.41	129.89	76.83	113.72
Current Liabilities
Accounts Payable	1.27	2.22	1.40	1.08
Accrued Liabilities	6.86	4.94	3.90	0.90
Other Current Liabilities	6.86	0.00	0.09	0.21
Total Current Liabilities	8.14	9.36	7.73	3.87
Non-Current Liabilities
Long-Term Debt	47.63	0.00	2.85	0.00
Other Non-Current Liabilities	0.00	0.00	0.01	0.10
Total Non-Current Liabilities	47.63	247.62	150.80	148.04
Total Liabilities	55.77	9.36	10.58	151.91
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-201.47	-136.11	-86.68	-40.77
Accumulated Other Comprehensive Income	0.12	0.04	-0.40	-0.18
Additional Paid-in Capital	351.99	8.99	5.38	2.76
Shares Outstanding	22.30	22.24	22.24	22.24
Total Stockholders' Equity	150.64	120.54	66.25	-38.19
Total Liabilities & Equity	206.41	129.89	76.83	113.72